|
시장보고서
상품코드
2016574
매독 검사 시장 : 유형, 검사 장소, 지역별(2026-2034년)Syphilis Testing Market by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and Region 2026-2034 |
||||||
세계의 매독 검사 시장 규모는 2025년에 13억 4,000만 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 20억 7,000만 달러에 달하며, 2026-2034년에 CAGR 4.82%로 성장할 것으로 예측하고 있습니다. 성병(STD)의 확산, 유산의 증가, 의료 분야에서 효과적인 질병 진단 및 검사 솔루션에 대한 수요 증가가 시장을 주도하는 주요 요인으로 작용하고 있습니다.
매독은 보통 성적 접촉에 의해 발생하며 피부나 점막 접촉을 통해 감염되는 성병(STI)을 말합니다. 초기 증상은 생식기, 직장, 입안에 생기는 무통성 궤양입니다. 치료를 소홀히 하면 3기 매독의 합병증을 유발할 수 있으며, 이 경우 뇌, 신경, 혈관, 관절에 손상을 입힐 수 있습니다. 현재 신속 혈장 반응 검사(RPR)와 성병 검사실 검사(VDRL)는 의료진에 의해 채택되고 있는 표준 검사법입니다. 이러한 방법들은 성병(STD)의 조기 발견과 적절한 치료를 가능하게 하고, 성병의 확산과 진행을 억제할 수 있습니다. 그 결과, 매독 검사는 매독의 유형을 진단하고 적절한 치료법을 확인하기 위해 검사실이나 PoC(Point of Care) 센터에서 자주 이용되고 있습니다.
매독 검사 시장 동향:
성병(STD) 치료에 대한 인식이 높아지면서 시장 성장을 이끄는 주요 요인 중 하나가 되고 있습니다. 이에 따라 각국 정부와 다양한 비정부기구(NGO)는 매독을 포함한 성병의 예방과 치료법에 대한 일반 대중의 인식을 높이기 위한 캠페인을 적극적으로 전개하고 있습니다. 이는 매독 신속 검사 스트립과 같은 검사 키트의 보급을 촉진하여 시장 성장을 촉진하고 있습니다. 이러한 키트는 집에서 검사를 하면서 정확한 진단 결과를 얻을 수 있고, 이를 통해 신속한 의사결정을 내릴 수 있으며, 시장 성장에 기여하고 있습니다. 또한 사용의 편리함과 더불어 온라인 소매점이나 오프라인 약국에서 저렴한 가격으로 쉽게 구할 수 있다는 점도 시장 성장을 촉진하고 있습니다. 이와 더불어, 의료 분야의 눈부신 발전과 효과적인 치료 옵션을 시장에 출시하기 위한 최근 연구개발(R&D) 활동도 시장 성장에 긍정적인 영향을 미치고 있습니다. 또한 성병 검사에 대한 유리한 의료비 환급 정책의 존재도 시장 성장에 기여하고 있습니다. 매독을 포함한 성병(STD)의 유병률 증가, 무방비 성관계 발생률 증가, 효과적인 검진 프로그램의 광범위한 시행, 질병의 조기 진단에 대한 관심 증가 등의 요인으로 인해 시장 전망이 밝아지고 있습니다.
이 보고서에서 답변하는 주요 질문
- 지금까지의 세계 매독 검사 시장 동향은 어떠했으며, 향후 수년간 어떻게 변화하는가?
- 세계의 매독 검사 시장 촉진요인, 제약 요인 및 기회는 무엇인가?
- 주요 지역 시장은 어디인가?
- 가장 매력적인 매독 검사 시장을 형성하고 있는 국가는 어디인가?
- 시장 유형별 시장 분석은?
- 검사 실시 장소에 따른 시장 분석은?
- 세계 매독 검사 시장의 경쟁 구조는 어떠한가?
- 세계의 매독 검사 시장의 주요 플레이어/기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 매독 검사 시장
제6장 시장 내역 : 유형별
제7장 시장 내역 : 시행 장소별
제8장 시장 내역 : 지역별
제9장 촉진요인·억제요인·기회
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
제12장 가격 분석
제13장 경쟁 구도
KSA 26.05.07The global syphilis testing market size reached USD 1.34 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.07 Billion by 2034, exhibiting a growth rate (CAGR) of 4.82% during 2026-2034. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences of miscarriages, and the rising need for effective disease diagnosing and testing solutions in the healthcare sector represent some of the key factors driving the market.
Syphilis refers to a sexually transmitted infection (STI) that is usually caused by sexual contact and is spread amongst individuals through the skin or mucous membrane contact. It starts as a painless sore on the genitals and rectum of the mouth. If left untreated, it might trigger complications of tertiary syphilis, wherein the disease may damage the brain, nerves, blood vessels, and joints. At present, rapid plasma reagin (RPR) and venereal diseases research laboratory (VDRL) are standard testing practices that are being used by practitioners. These approaches provide early detection for better treatment and mitigate the spread and development of sexually transmitted diseases (STDs). As a result, syphilis testing is frequently used in laboratories and point-of-care (PoC) centers to diagnose the syphilis type and identify its proper treatment.
SYPHILIS TESTING MARKET TRENDS:
The increasing awareness regarding STD treatment represents one of the key factors driving the market growth. In line with this, governments of various nations, along with different non-governmental organizations (NGOs) are actively undertaking campaigns to sensitize the common mass regarding the prevention of STDs, including syphilis, and the available treatment options. This, in turn, is facilitating the adoption of syphilis testing kits, such as syphilis rapid test strips, which is favorably supporting the market growth. These kits offer at-home testing with effective diagnostic results, and thus timely decision-making, which is also contributing to the market growth. Additionally, the convenience of usage and the easy availability of these test kits at online retail stores and in-store pharmacies at affordable price points are contributing to the market growth. Apart from this, the considerable improvements in the healthcare sector and the recent research and development (R&D) activities to launch effective treatment alternatives are positively impacting the market growth. Moreover, the presence of favorable medical reimbursement policies for the testing of sexually transmitted infections is contributing to the market growth. Other factors, such as the increasing prevalence of STDs, including syphilis, rising incidences of unprotected sexual intercourse, the widespread implementation of effective screening programs, and an enhanced focus on the early diagnostic of the disease, are creating a positive outlook for the market.
KEY MARKET SEGMENTATION:
Type Insights:
- Primary and Secondary Syphilis
- Latent and Tertiary Syphilis
The report has also provided a detailed breakup and analysis of the syphilis testing market based on the type. This includes primary and secondary, and latent and tertiary syphilis. According to the report, primary and secondary syphilis represented the largest segment.
Location of Testing Insights:
- Laboratory Testing
- Point-of-Care (POC) Testing
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for syphilis testing. Some of the factors driving the North America syphilis testing market included the increasing prevalence of STDs, significant technological advancements, and extensive research and development (R&D) activities.
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global syphilis testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered includes Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, DRG International Inc. (BioCheck Inc.), F. Hoffmann-La Roche AG, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global syphilis testing market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global syphilis testing market?
- What are the key regional markets?
- Which countries represent the most attractive syphilis testing markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the location of testing?
- What is the competitive structure of the global syphilis testing market?
- Who are the key players/companies in the global syphilis testing market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Syphilis Testing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Primary and Secondary Syphilis
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Latent and Tertiary Syphilis
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Location of Testing
- 7.1 Laboratory Testing
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Point-of-Care (POC) Testing
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
- 9.1 Overview
- 9.2 Drivers
- 9.3 Restraints
- 9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Abbott Laboratories
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Becton Dickinson and Company
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Bio-Rad Laboratories Inc.
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Danaher Corporation
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 DRG International Inc. (BioCheck Inc.)
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.6 F. Hoffmann-La Roche AG
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.7 Siemens Healthineers AG (Siemens AG)
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Thermo Fisher Scientific Inc.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.1 Abbott Laboratories
